Rockefeller Capital Management L.P. Dare Bioscience, Inc. Transaction History
Rockefeller Capital Management L.P.
- $34.7 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding DARE
# of Institutions
14Shares Held
5.16MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.36MShares$14.8 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny779KShares$3.43 Million0.0% of portfolio
-
State Street Corp Boston, MA282KShares$1.24 Million0.0% of portfolio
-
Black Rock Inc. New York, NY204KShares$895,9800.0% of portfolio
-
Northern Trust Corp Chicago, IL185KShares$816,1340.0% of portfolio
About Dare Bioscience, Inc.
- Ticker DARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,820,896
- Market Cap $373M
- Description
- Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...